| Home Market Dynamics Sector Analysis Company Insights AI Investing Strategies Contact Us Login |
| Eli Lilly is prominently advancing its product development efforts, particularly focusing on innovative cancer therapies such as Verzenio, which has shown significant survival benefits. The company is also experiencing growth in its obesity and diabetes drug sectors, exemplified by products like Mounjaro and Zepbound, emphasizing its commitment to innovation and market leadership. This strong focus on developing effective medical solutions positions Lilly favorably within the pharmaceutical landscape. However, competition in the drug development space remains a challenge, necessitating continuous innovation to maintain a competitive edge. |
| The price action of Eli Lilly (LLY) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The market sentiment at 0.3 is modestly bullish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next.There is no clear direction for LLY since trend sentiment and market sentiment are at the opposite directions. The positive sentiment force for sector is at 0.5, and the negative at -0.2 on 2025-10-23. The forces of and Valuation Sentiment (-1) will drive down the price. The forces of Stock Price Trend (0), Sector Price Trend (0), Price Level Sentiment (0), Option Sentiment (0), Market Risk Appetite (0), and Sentiment towards Fundamentals (2.8) will drive up the price. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
| LLY | |||||||||||||
| Date | Attention | Price | Price Level | Change | SMA10 Trend | Trend Sentiment | Hourly Trend | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-10-23 | 0%(0%) | 0 | 0% | 0.3 | 2.8 | -1 | |||||||
| 2025-10-22 | 0%(0%) | 0 | 0% | 0.2 | 2.4 | -1 | |||||||
| 2025-10-21 | 0%(0%) | 0 | 0% | 0.4 | 3.1 | -1 | |||||||
| 2025-10-20 | 0%(0%) | 0 | 0% | 0.4 | 3.2 | -1 | |||||||
| 2025-10-19 | 0%(0%) | 0 | 0% | 0.5 | 3.7 | -1 | |||||||
| 2025-10-18 | 0%(0%) | 0 | 0% | 0.4 | 3.5 | -1 | |||||||
| 2025-10-17 | 0%(0%) | 0 | 0% | 0.5 | 3.9 | -6 | |||||||
| 2025-10-16 | 0%(0%) | 0 | 0% | 0.5 | 3.9 | -7 | |||||||
| 2025-10-15 | 0%(0%) | 0 | 0% | 0.6 | 4.6 | -1 | |||||||
| 2025-10-14 | 0%(0%) | 0 | 0% | 0.6 | 4.6 | -1 | |||||||
| Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | |||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | |||||||||||||
| 2025-10-23 17:01:58 The article notes the broader recovery in the drug and biotech sector, which impacts Lilly's performance and outlook. |
| 2025-10-23 17:01:58 The agreement with Cipla highlights Eli Lilly's strategic partnerships to expand its market presence in India. |
| 2025-10-23 17:01:58 Lilly's advancements in obesity and diabetes drug development showcase its commitment to innovation and market leadership. |
| 2025-10-23 17:01:58 Expectations surrounding Eli Lilly's upcoming earnings report indicate a focus on its potential growth despite mixed analyst opinions. |
| 2025-10-23 17:01:58 Eli Lilly's stock has shown a significant increase, reflecting positive market sentiment and investor confidence in the company's growth prospects. |